Fingerprint Dive into the research topics of 'Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically